| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.56 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.38 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-20 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-15 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |